2023 Q1 Form 10-Q Financial Statement

#000109166723000084 Filed on April 28, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4
Revenue $13.65B $13.67B
YoY Change 3.43% 3.5%
Cost Of Revenue $7.565B $7.456B
YoY Change 3.52% 4.43%
Gross Profit $6.088B $6.218B
YoY Change 3.33% 2.4%
Gross Profit Margin 44.59% 45.47%
Selling, General & Admin $946.0M $846.0M
YoY Change 14.53% 6.95%
% of Gross Profit 15.54% 13.61%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.206B $2.192B
YoY Change -3.84% -3.86%
% of Gross Profit 36.24% 35.25%
Operating Expenses $8.511B $3.038B
YoY Change 4.63% -1.07%
Operating Profit $2.926B $3.180B
YoY Change 5.59% 5.96%
Interest Expense -$1.371B -$1.244B
YoY Change 31.07% 4.63%
% of Operating Profit -46.86% -39.12%
Other Income/Expense, Net -$104.0M $13.00M
YoY Change -552.17% -89.92%
Pretax Income $1.557B $1.804B
YoY Change -10.21% -12.34%
Income Tax $374.0M $419.0M
% Of Pretax Income 24.02% 23.23%
Net Earnings $1.021B $1.196B
YoY Change -15.13% -25.71%
Net Earnings / Revenue 7.48% 8.75%
Basic Earnings Per Share $6.74
Diluted Earnings Per Share $6.65 $7.682M
COMMON SHARES
Basic Shares Outstanding 151.4M shares
Diluted Shares Outstanding 153.5M shares

Balance Sheet

Concept 2023 Q1 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $534.0M $645.0M
YoY Change -78.03% 7.32%
Cash & Equivalents $534.0M $645.0M
Short-Term Investments
Other Short-Term Assets $682.0M $451.0M
YoY Change 22.88% 16.84%
Inventory
Prepaid Expenses
Receivables $2.851B $2.921B
Other Receivables $0.00 $0.00
Total Short-Term Assets $4.067B $4.017B
YoY Change -26.27% 12.65%
LONG-TERM ASSETS
Property, Plant & Equipment $36.60B $36.04B
YoY Change 7.11% 5.04%
Goodwill $29.56B $29.56B
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $991.0M
YoY Change 784.82%
Other Assets $4.793B $4.769B
YoY Change 31.32% 30.77%
Total Long-Term Assets $140.8B $140.5B
YoY Change 1.71% 1.14%
TOTAL ASSETS
Total Short-Term Assets $4.067B $4.017B
Total Long-Term Assets $140.8B $140.5B
Total Assets $144.9B $144.5B
YoY Change 0.64% 1.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $746.0M $952.0M
YoY Change 5.67% 31.49%
Accrued Expenses $8.974B $9.092B
YoY Change 9.47% 9.86%
Deferred Revenue $511.0M
YoY Change 10.85%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.999B $1.510B
YoY Change -56.0% -49.62%
Total Short-Term Liabilities $12.24B $12.07B
YoY Change -12.11% -3.15%
LONG-TERM LIABILITIES
Long-Term Debt $95.97B $96.09B
YoY Change 5.84% 8.5%
Other Long-Term Liabilities $4.723B $4.758B
YoY Change 9.18% 12.83%
Total Long-Term Liabilities $100.7B $100.9B
YoY Change 5.99% 8.7%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.24B $12.07B
Total Long-Term Liabilities $100.7B $100.9B
Total Liabilities $112.9B $112.9B
YoY Change 3.68% 7.29%
SHAREHOLDERS EQUITY
Retained Earnings -$13.80B -$14.82B
YoY Change 20.29% 16.93%
Common Stock $24.14B $23.94B
YoY Change -10.15% -10.42%
Preferred Stock
YoY Change
Treasury Stock (at cost) $920.0M $0.00
YoY Change -72.4%
Treasury Stock Shares
Shareholders Equity $9.418B $9.119B
YoY Change
Total Liabilities & Shareholders Equity $144.9B $144.5B
YoY Change 0.64% 1.43%

Cashflow Statement

Concept 2023 Q1 2022 Q4
OPERATING ACTIVITIES
Net Income $1.021B $1.196B
YoY Change -15.13% -25.71%
Depreciation, Depletion And Amortization $2.206B $2.192B
YoY Change -3.84% -3.86%
Cash From Operating Activities $3.323B $3.787B
YoY Change -8.88% -10.39%
INVESTING ACTIVITIES
Capital Expenditures $2.464B -$2.920B
YoY Change 32.69% 40.93%
Acquisitions
YoY Change
Other Investing Activities $80.00M $152.0M
YoY Change -233.33% 90.0%
Cash From Investing Activities -$2.739B -$2.768B
YoY Change 53.27% 38.96%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $912.0M
YoY Change -72.64%
Debt Paid & Issued, Net $6.740B
YoY Change 128.17%
Cash From Financing Activities -$695.0M -854.0M
YoY Change 2216.67% -59.31%
NET CHANGE
Cash From Operating Activities $3.323B 3.787B
Cash From Investing Activities -$2.739B -2.768B
Cash From Financing Activities -$695.0M -854.0M
Net Change In Cash -$111.0M 165.0M
YoY Change -106.07% 22.22%
FREE CASH FLOW
Cash From Operating Activities $3.323B $3.787B
Capital Expenditures $2.464B -$2.920B
Free Cash Flow $859.0M $6.707B
YoY Change -52.01% 6.49%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001091667
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-33664
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Charter Communications, Inc.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-1496755
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
400 Washington Blvd.
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Stamford
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CT
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
06902
CY2023Q1 dei City Area Code
CityAreaCode
203
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
905-7801
CY2023Q1 dei Security12b Title
Security12bTitle
Class A Common Stock $.001 Par Value
CY2023Q1 dei Trading Symbol
TradingSymbol
CHTR
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
534000000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
645000000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
211000000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
219000000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2851000000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2921000000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
682000000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
451000000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
4067000000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
4017000000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
36644000000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
36164000000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
36602000000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
36039000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
15777000000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
15478000000 usd
CY2023Q1 chtr Customer Relationships Net
CustomerRelationshipsNet
2479000000 usd
CY2022Q4 chtr Customer Relationships Net
CustomerRelationshipsNet
2772000000 usd
CY2023Q1 us-gaap Indefinite Lived Franchise Rights
IndefiniteLivedFranchiseRights
67366000000 usd
CY2022Q4 us-gaap Indefinite Lived Franchise Rights
IndefiniteLivedFranchiseRights
67363000000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
29563000000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
29563000000 usd
CY2023Q1 chtr Total Investment In Cable Properties Net
TotalInvestmentInCablePropertiesNet
136010000000 usd
CY2022Q4 chtr Total Investment In Cable Properties Net
TotalInvestmentInCablePropertiesNet
135737000000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4793000000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4769000000 usd
CY2023Q1 us-gaap Assets
Assets
144870000000 usd
CY2022Q4 us-gaap Assets
Assets
144523000000 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
10243000000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
10555000000 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
1999000000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1510000000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
12242000000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12065000000 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
95973000000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
96093000000 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
19030000000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
19058000000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4723000000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4758000000 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
250000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
250000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
24138000000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
23940000000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-13800000000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14821000000 usd
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
2472915 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
0 shares
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
920000000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
0 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
9418000000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
9119000000 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
3484000000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
3430000000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
12902000000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
12549000000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
144870000000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
144523000000 usd
CY2023Q1 us-gaap Revenues
Revenues
13653000000 usd
CY2022Q1 us-gaap Revenues
Revenues
13200000000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
8511000000 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
8134000000 usd
CY2023Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
2206000000 usd
CY2022Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
2294000000 usd
CY2023Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-10000000 usd
CY2022Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1000000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
10727000000 usd
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
10429000000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
2926000000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
2771000000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1265000000 usd
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1060000000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-104000000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
23000000 usd
CY2023Q1 chtr Total Nonoperating Income Expense Including Interest Expense Net
TotalNonoperatingIncomeExpenseIncludingInterestExpenseNet
-1369000000 usd
CY2022Q1 chtr Total Nonoperating Income Expense Including Interest Expense Net
TotalNonoperatingIncomeExpenseIncludingInterestExpenseNet
-1037000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1557000000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1734000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
374000000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
345000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
1183000000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
1389000000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
162000000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
186000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1021000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
1203000000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.74
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
7.05
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.65
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.90
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
151438371 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
170688127 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
153538359 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
174500472 shares
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
12549000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
1183000000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
208000000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2000000 usd
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
920000000 usd
CY2023Q1 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
108000000 usd
CY2023Q1 chtr Noncontrolling Interest Increase Decrease From Changes In Subsidiary Ownership
NoncontrollingInterestIncreaseDecreaseFromChangesInSubsidiaryOwnership
-9000000 usd
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
3000000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
12902000000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
18156000000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
1389000000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
147000000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1000000 usd
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3333000000 usd
CY2022Q1 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
353000000 usd
CY2022Q1 chtr Noncontrolling Interest Increase Decrease From Changes In Subsidiary Ownership
NoncontrollingInterestIncreaseDecreaseFromChangesInSubsidiaryOwnership
-61000000 usd
CY2022Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
2000000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
15944000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
1183000000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
1389000000 usd
CY2023Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
2206000000 usd
CY2022Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
2294000000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
208000000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
147000000 usd
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-3000000 usd
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-3000000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-23000000 usd
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
38000000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-104000000 usd
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
21000000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-70000000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-49000000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
336000000 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
185000000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-86000000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-61000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3323000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3647000000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2464000000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1857000000 usd
CY2023Q1 chtr Changes In Accrued Expenses Related To Capital Expenditures
ChangesInAccruedExpensesRelatedToCapitalExpenditures
195000000 usd
CY2022Q1 chtr Changes In Accrued Expenses Related To Capital Expenditures
ChangesInAccruedExpensesRelatedToCapitalExpenditures
-10000000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
80000000 usd
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-60000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2739000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1787000000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
7104000000 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
6713000000 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
6740000000 usd
CY2022Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2954000000 usd
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
18000000 usd
CY2022Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
37000000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
912000000 usd
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3333000000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2000000 usd
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1000000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
122000000 usd
CY2022Q1 us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
416000000 usd
CY2023Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
3000000 usd
CY2022Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
2000000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-6000000 usd
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-2000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-695000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-30000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-111000000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1830000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
645000000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
601000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
534000000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2431000000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
1189000000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
982000000 usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
61000000 usd
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
29000000 usd
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2023Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
746000000 usd
CY2022Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
952000000 usd
CY2023Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
523000000 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
511000000 usd
CY2023Q1 us-gaap Program Rights Obligations Current
ProgramRightsObligationsCurrent
1882000000 usd
CY2022Q4 us-gaap Program Rights Obligations Current
ProgramRightsObligationsCurrent
1914000000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
959000000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1314000000 usd
CY2023Q1 chtr Accrued Capital Expenditures
AccruedCapitalExpenditures
1592000000 usd
CY2022Q4 chtr Accrued Capital Expenditures
AccruedCapitalExpenditures
1792000000 usd
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
1248000000 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1165000000 usd
CY2023Q1 chtr Accrued Taxes And Regulatory Fees Current
AccruedTaxesAndRegulatoryFeesCurrent
970000000 usd
CY2022Q4 chtr Accrued Taxes And Regulatory Fees Current
AccruedTaxesAndRegulatoryFeesCurrent
667000000 usd
CY2023Q1 chtr Accrued Property And Casualty Insurance Current
AccruedPropertyAndCasualtyInsuranceCurrent
502000000 usd
CY2022Q4 chtr Accrued Property And Casualty Insurance Current
AccruedPropertyAndCasualtyInsuranceCurrent
505000000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
292000000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
295000000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1529000000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1440000000 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
10243000000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
10555000000 usd
CY2023Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
97763000000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
97972000000 usd
CY2023Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
85541000000 usd
CY2022Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
97368000000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
97603000000 usd
CY2022Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
82798000000 usd
CY2023Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
2472915 shares
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
912000000 usd
CY2022Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
5739096 shares
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3333000000 usd
CY2023Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
305000000 usd
CY2023Q1 us-gaap Revenues
Revenues
13653000000 usd
CY2023Q1 chtr Noncontrolling Interest Purchaseof Interests Shares Purchased
NoncontrollingInterestPurchaseofInterestsSharesPurchased
324100 shares
CY2022Q1 chtr Noncontrolling Interest Purchaseof Interests Shares Purchased
NoncontrollingInterestPurchaseofInterestsSharesPurchased
657268 shares
CY2023Q1 chtr Minority Interest Decrease From Redemptions Purchase Price
MinorityInterestDecreaseFromRedemptionsPurchasePrice
122000000 usd
CY2022Q1 chtr Minority Interest Decrease From Redemptions Purchase Price
MinorityInterestDecreaseFromRedemptionsPurchasePrice
416000000 usd
CY2022Q1 us-gaap Revenues
Revenues
13200000000 usd
CY2023Q1 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
5000000 usd
CY2022Q1 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-36000000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-32000000 usd
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
50000000 usd
CY2023Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-27000000 usd
CY2022Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
14000000 usd
CY2023Q1 chtr Programming Expense
ProgrammingExpense
2799000000 usd
CY2022Q1 chtr Programming Expense
ProgrammingExpense
2977000000 usd
CY2023Q1 chtr Franchise Regulatory And Connectivity Expense
FranchiseRegulatoryAndConnectivityExpense
1328000000 usd
CY2022Q1 chtr Franchise Regulatory And Connectivity Expense
FranchiseRegulatoryAndConnectivityExpense
1108000000 usd
CY2023Q1 chtr Cost To Service Customers
CostToServiceCustomers
2095000000 usd
CY2022Q1 chtr Cost To Service Customers
CostToServiceCustomers
1959000000 usd
CY2023Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
946000000 usd
CY2022Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
880000000 usd
CY2023Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
1343000000 usd
CY2022Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
1210000000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
8511000000 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
8134000000 usd
CY2023Q1 us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
10000000 usd
CY2022Q1 us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
-1000000 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-2000000 usd
CY2023Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-10000000 usd
CY2022Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1000000 usd
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18000000 shares
CY2023Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-27000000 usd
CY2022Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
14000000 usd
CY2023Q1 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-2000000 usd
CY2022Q1 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-17000000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-79000000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-8000000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-104000000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
23000000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
208000000 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
147000000 usd
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21000000 shares
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1021000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
1203000000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
151438371 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
170688127 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2099988 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3812345 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
153538359 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
174500472 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.74
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
7.05
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.65
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.90

Files In Submission

Name View Source Status
chtr-20230331_lab.xml Edgar Link unprocessable
0001091667-23-000084-index-headers.html Edgar Link pending
0001091667-23-000084-index.html Edgar Link pending
0001091667-23-000084.txt Edgar Link pending
0001091667-23-000084-xbrl.zip Edgar Link pending
chtr-20230331.htm Edgar Link pending
chtr-20230331.xsd Edgar Link pending
chtr-20230331_g1.jpg Edgar Link pending
chtr3312023exh-311.htm Edgar Link pending
chtr3312023exh-312.htm Edgar Link pending
chtr3312023exh-321.htm Edgar Link pending
chtr3312023exh-322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
chtr-20230331_cal.xml Edgar Link unprocessable
chtr-20230331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
chtr-20230331_htm.xml Edgar Link completed
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
chtr-20230331_def.xml Edgar Link unprocessable